Great Novel Therapeutics Biotech & Medicals (ROCO:7427) YoY Rev. per Sh. Growth : 1,250.00% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Great Novel Therapeutics Biotech & Medicals YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Great Novel Therapeutics Biotech & Medicals's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2024 was 1,250.00%.

Great Novel Therapeutics Biotech & Medicals's Revenue per Share for the six months ended in Dec. 2024 was NT$0.03.

Great Novel Therapeutics Biotech & Medicals YoY Rev. per Sh. Growth Historical Data

The historical data trend for Great Novel Therapeutics Biotech & Medicals's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Great Novel Therapeutics Biotech & Medicals YoY Rev. per Sh. Growth Chart

Great Novel Therapeutics Biotech & Medicals Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

-100.00

-20.00

570.00

-69.40

Great Novel Therapeutics Biotech & Medicals Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial							-100.00	504.35	-	-89.93	1,250.00

Great Novel Therapeutics Biotech & Medicals YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Great Novel Therapeutics Biotech & Medicals's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2024 )
=	(Revenue per Share (A: Dec. 2024 )	-	Revenue per Share (A: Dec. 2023 ))	/	\| Revenue per Share (A: Dec. 2023 ) \|
=	(0.041	-	0.134)	/	\| 0.134 \|
=	-69.40 %

Great Novel Therapeutics Biotech & Medicals's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Dec. 2024 )
=	(Revenue per Share (Q: Dec. 2024 )	-	Revenue per Share (Q: Dec. 2023 ))	/	\| Revenue per Share (Q: Dec. 2023 )) \|
=	(0.027	-	0.002)	/	\| 0.002 \|
=	1,250.00 %

Great Novel Therapeutics Biotech & Medicals YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Great Novel Therapeutics Biotech & Medicals's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Great Novel Therapeutics Biotech & Medicals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Great Novel Therapeutics Biotech & Medicals (ROCO:7427) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.3, Park Street, Room WR-06, 17th Floor, Nangang District, Taipei, TWN, 11503

Website

http://www.gntbm.com.tw

Great Novel Therapeutics Biotech & Medicals focuses on drug development to treat advanced cancer. The new drugs ranging from epigenetic modulators, a combination of tumor microenvironment-regulating agents, epigenetic immuno-modulators, to the protein degradation drugs targeting HDACs 1, 2, and 3, are in a developing pipeline. These drugs focus on the field of epigenetics, for the demand of clinical unmet needs in advanced and refractory cancers.

Great Novel Therapeutics Biotech & Medicals Headlines

No Headlines